Under construction – not a live service
Sign in
Taking people in United StatesPhase 1/2

Tests safety of human neural stem cells in Huntington's disease

Tests whether implanted hNSC-01 cells are safe for adults with Huntington's disease.

Plain-language title generated from the registry record
Registry title: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Key facts

Where
Irvine, United StatesSee the site
Phase
Phase 1/2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07451613, who can take part

Where in United States

  • University of California, IrvineIrvine, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Leslie Thompson
Trial code
NCT07451613
Record updated
13 April 2026
Original description
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.Read full original descriptionShow less

Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease

The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.

Inclusion: Have decision-making capacity and be able to provide written informed consent; Are between 18 to 65 years of age; Have genetically confirmed diagnosis of Huntington's Disease; Able to undergo MRI scans, tolerate neurosurgical procedure, blood draws and lumbar puncture.

Exclusion: Test positive for human immunodeficiency virus (HIV), hepatitis C or chronic hepatitis B at Screening; Are pregnant; Have an implanted deep brain stimulation device.

Please note this may not be a complete list of eligibility criteria.

ClinicalTrials.gov NCT07451613

Under construction, not live – Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease (NCT07451613) – Frontlight Research